Similar articles for PMID: 35675941

Year	Number of Results
2008	2
2009	6
2010	10
2011	14
2012	14
2013	10
2014	11
2015	6
2016	5
2017	8
2018	2
2019	10
2020	13
2021	19
2022	31
2023	17
2024	0

1

Autologous peripheral blood stem cell mobilization and collection in patients with lymphoma and multiple myeloma: A single-center experience using the plerixa for pre-emptive approach.

Alsaeed AS, Najib MJ, Al Amoudi SM, Elhemaidi IY, Absi AA, Al Ahmadi MD, Eldadah SK, Rajkhan WA, Khalil MM, Almohammadi MH. Alsaeed AS, et al. Saudi Med J. 2022 Jun;43(6):626-632. doi: 10.15537/smj.2022.43.6.20210912. Saudi Med J. 2022. PMID: 35675941 Free PMC article.

2

Successful Mobilization of Autologous Hematopoietic Peripheral Blood Stem Cells after Salvage Chemotherapy in Patients with Low CD34 Blood Cell Counts.

Holmberg LA, Linenberger M, Connelly-Smith L. Holmberg LA, et al. Transplant Cell Ther. 2022 Nov;28(11):754-759. doi: 10.1016/j.jtct.2022.08.017. Epub 2022 Aug 22. Transplant Cell Ther. 2022. PMID: 36002104 Free article.

3

Development of a quantitative prediction model for peripheral blood stem cell collection yield in the plerixafor era.

Ishii A, Jo T, Arai Y, Oshima S, Kanda J, Kitawaki T, Matsui K, Niwa N, Nakagawa Y, Takaori-Kondo A, Nagao M. Ishii A, et al. Cytotherapy. 2022 Jan;24(1):49-58. doi: 10.1016/j.jcyt.2021.09.004. Epub 2021 Oct 12. Cytotherapy. 2022. PMID: 34654641 Free article.

4

Impact of Plerixafor Use at Different Peripheral Blood CD34⁺ Thresholds on Autologous Stem Cell Collection in Patients with Multiple Myeloma.

Shah EE, Young RP, Wong SW, Damon LE, Wolf JL, Shah ND, Leavitt AD, Loeffler P, Martin TG 3rd. Shah EE, et al. Biol Blood Marrow Transplant. 2020 May;26(5):876-883. doi: 10.1016/j.bbmt.2019.11.024. Epub 2019 Nov 27. Biol Blood Marrow Transplant. 2020. PMID: 31785375 Free article.

5

[Mobilization of peripheral blood stem cells with plerixafor in poor mobilizer patients].

Sancho JM, Duarte R, Medina L, Querol S, Marín P, Sureda A; en representación del Grupo de Trabajo de Movilización de la Sociedad Catalana de Hematología y Hemoterapia y de la Sociedad Catalano-Balear de Transfusión Sanguínea. Sancho JM, et al. Med Clin (Barc). 2016 Sep 2;147(5):223.e1-223.e7. doi: 10.1016/j.medcli.2016.05.019. Epub 2016 Jun 30. Med Clin (Barc). 2016. PMID: 27374031 Spanish.

6

Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma.

Hartmann T, Hübel K, Monsef I, Engert A, Skoetz N. Hartmann T, et al. Cochrane Database Syst Rev. 2015 Oct 20;2015(10):CD010615. doi: 10.1002/14651858.CD010615.pub2. Cochrane Database Syst Rev. 2015. PMID: 26484982 Free PMC article. Review.

7

Incidence and risk factors of poor mobilization in adult autologous peripheral blood stem cell transplantation: a single-centre experience.

Lee KH, Jung SK, Kim SJ, Jang JH, Kim K, Kim WS, Jung CW, Kim DW, Kang ES. Lee KH, et al. Vox Sang. 2014 Nov;107(4):407-15. doi: 10.1111/vox.12183. Epub 2014 Jul 31. Vox Sang. 2014. PMID: 25130876

8

Threshold for optimal administration of plerixafor in autologous peripheral blood stem cell collections through CD34+ cell monitoring based on the experience from two Japanese university hospitals.

Okubo M, Furuta Y, Nakamura Y, Osawa T, Tada N, Sawada T, Yamatoya K, Sekiguchi Y, Araki Y, Miyake K, Noguchi M, Komatsu N, Ohsaka A. Okubo M, et al. Ther Apher Dial. 2021 Oct;25(5):687-696. doi: 10.1111/1744-9987.13614. Epub 2021 Jan 7. Ther Apher Dial. 2021. PMID: 33325621

9

Are we choosing mobilization regimens for autologous stem cell transplantation in multiple myeloma wisely: A single center comparison of GCSF+/-plerixafor vs cyclophosphamide/GCSF+/-plerixafor.

Yang C, Dehghani M, Hopman W, Bhella S. Yang C, et al. J Clin Apher. 2022 Aug;37(4):348-353. doi: 10.1002/jca.21976. Epub 2022 Feb 26. J Clin Apher. 2022. PMID: 35218068

10

The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma.

Tolomelli G, Mancuso K, Tacchetti P, Patriarca F, Galli M, Pantani L, Zannetti B, Motta MR, Rizzi S, Dan E, Sinigaglia B, Giudice V, Olmo A, Arpinati M, Chirumbolo G, Fanin R, Lewis RE, Paris L, Bonifazi F, Cavo M, Curti A, Lemoli RM. Tolomelli G, et al. Bone Marrow Transplant. 2020 May;55(5):946-954. doi: 10.1038/s41409-019-0756-1. Epub 2019 Nov 25. Bone Marrow Transplant. 2020. PMID: 31768009

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

137 results

Results by year